Skip to main content
Reuben Ram, MD, Family Medicine, Burbank, CA

ReubenJubinRamMD

Family Medicine • Burbank, CA

Sleep Medicine

UCLA Toluca Lake Health Center Sleep Medicine and Family Medicine

Join to view full profile

Dr. Ram is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ram's full profile

Already have an account?

  • Office

    Toluca Lake Health Center
    4323 Riverside Dr.
    Burbank, CA 91505
    Phone+1 818-556-2700
    Fax+1 818-295-3470

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Sleep Medicine, 2015 - 2016
  • Dignity Health Northridge Hospital Medical Center
    Dignity Health Northridge Hospital Medical CenterResidency, Family Medicine, 2012 - 2015
  • American University of the Caribbean School of Medicine
    American University of the Caribbean School of MedicineClass of 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2026
  • American Board of Family Medicine Family Medicine
  • American Board of Family Medicine Sleep Medicine

Awards, Honors, & Recognition

  • Los Angeles Top Doctors Los Angeles Magazine, 2021
  • Resident of the Year
  • Distinguished Research Scholar
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Insomnia And OSA In A Veteran Cohort Referred For Sleep Evaluation
    1. Ram RJ, Zeidler M, Mitchell M, Jouldjian S, Martin JL, SLEEP
  • 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Treatment Decreases Epicardial and Pericardial Adipose Tissue in Patients with Recent Acute Coronary Syndrome
    3. Ram RJ, Nabavi Larijani V, Flores F, Prabhu S, Ram N, Baskett M, Ardestani A, Ahmadi N, Grégoire J, Pressacco J, Budoff M, Tardif J, Circulation, 2015
  • 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Intake Improves Left Ventricular Ejection Fraction Tissue in Patients with Recent Acute Coronary Syndrome
    2. Ram RJ, Nabavi Larijani V, Prabhu S, Dailing C, Ardestani A, Ram N, Ahmadi N, Ibrahim R, Pressacco J, Tardif J, Budoff M, Circulation, 2012

Professional Memberships

Dr. Reuben Ram, Dr. Reuben Ram, MD, Dr. R Ram, Dr. Reuben Jubin Ram